BioProcess International Europe
Understand how the brightest minds in bioprocessing are accelerating the development and production of their mAbs, therapeutic proteins, vaccines, and novel modalities by attending BioProcess International Europe, held 2-5 April 2019 in Vienna, Austria.
PAT Assisted Control Strategy for Continuous Downstream Processing
Margit Holzer, Scientific Director, Ulysse Consult, Luxembourg
Full Presentation: Thursday, 4 April 2019 14:00–14:30
Ahead of her presentation, Holzer speaks to BioProcess Insider about the benefits of incorporating integrated continuous processes into the downstream, and how process analytical technology (PAT) initiatives are helping to make this a reality. She also reflects on biomanufacturers’ efforts to adopt continuous downstream processing and how vendors and technology firms are aiding in this space.
Rapid Development of Cell Lines Suitable for Commercial Manufacturing
Martin Allen, Senior Director, Cell Line Development, Pfizer
Full Presentation: Wednesday, 3 April 2019 16:45–17:15
In this podcast, Allen talks about the significant efforts at Pfizer looking at streamlining its cell line developments, speeding up the development process for its next generation biological products. He says the firm can deliver cell lines for early phase development as well as long-term commercial manufacturing within weeks, and without the risks industry may have seen a decade ago.
Case Study from Shire: Global Implementation of Real Time Monitoring
Michael Backhaus Manufacturing Intelligence IT Lead, Shire, Austria
Full Presentation: Wednesday, 3 April 2019 12:00–12:30
Ahead of his presentation in his home city, he spoke to us about the advantages and challenges with the roll-out of global IT solutions and turning a decentralized manufacturing network into centralized IT platforms for advanced data analytics.
Backhaus also told us how the advent of real-time monitoring can help biopharma firms overcome numerous bottlenecks in the production process, improving input and yields, and how regulators are getting behind such platforms.
Plug and Play Automation for Single Use Equipment
Peter Neubauer, Department of Biotechnology, Technische Universität Berlin (TU Berlin)
Full Presentation: Friday, 5 April 2019 08:30–12:30
In this podcast, he tells us about why microbial based production has played second fiddle to mammalian cell culture systems and why this is likely to change going forward.
Some of the subjects he talks about include new technologies for primary recovery and cell harvesting, innovations in downstream, and developing a roadmap to perform effective scale up in microbial manufacturing. He also tells us how industry is working with academia to improve processes.
Bioprocess Innovations in the Era of Acceleration and Intensification
Stefanos Grammatikos, VP and Head of Biotech Sciences, UCB Pharma, Belgium
Full Presentation: Wednesday, 3 April 2019 08:30–09:00
His presentation will focus on innovations in biomanufacturing within this current era of acceleration and intensification.
In this podcast, he sets the scene of how industry got to this current point in bioprocessing, especially in reference to the changing clinical development landscape.
